These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1087 related articles for article (PubMed ID: 15305695)

  • 1. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum.
    Hommer V; Eichholz J; Petry F
    J Antimicrob Chemother; 2003 Sep; 52(3):359-64. PubMed ID: 12888587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indinavir reduces Cryptosporidium parvum infection in both in vitro and in vivo models.
    Mele R; Gomez Morales MA; Tosini F; Pozio E
    Int J Parasitol; 2003 Jul; 33(7):757-64. PubMed ID: 12814654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
    Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
    Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intestinal cryptosporidiosis in HIV infected children].
    Barboni G; Candi M; Inés Villacé M; Leonardelli A; Balbaryski J; Gaddi E
    Medicina (B Aires); 2008; 68(3):213-8. PubMed ID: 18689152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunosuppressed rat model for evaluation of anti-Cryptosporidium activity of sinefungin.
    Brasseur P; Favennec L; Leméteil D; Roussel F; Ballet JJ
    Folia Parasitol (Praha); 1994; 41(1):13-6. PubMed ID: 8050749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Human cryptosporidiosis and Cryptosporidium spp. in Haiti].
    Raccurt CP; Brasseur P; Verdier RI; Li X; Eyma E; Stockman CP; Agnamey P; Guyot K; Totet A; Liautaud B; Nevez G; Dei-Cas E; Pape JW
    Trop Med Int Health; 2006 Jun; 11(6):929-34. PubMed ID: 16772015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of selenium on Cryptosporidium parvum infection in vitro and in vivo.
    Huang K; Yang S
    Biol Trace Elem Res; 2002; 90(1-3):261-72. PubMed ID: 12666840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptosporidium parvum infection in experimentally infected mice: infection dynamics and effect of immunosuppression.
    Tarazona R; Blewett DA; Carmona MD
    Folia Parasitol (Praha); 1998; 45(2):101-7. PubMed ID: 9684319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors.
    Cassone A; De Bernardis F; Torosantucci A; Tacconelli E; Tumbarello M; Cauda R
    J Infect Dis; 1999 Aug; 180(2):448-53. PubMed ID: 10395861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum.
    Urban JF; Fayer R; Chen SJ; Gause WC; Gately MK; Finkelman FD
    J Immunol; 1996 Jan; 156(1):263-8. PubMed ID: 8598471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The loading of labelled antibody-engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum.
    Bondioli L; Ludovisi A; Tosi G; Ruozi B; Forni F; Pozio E; Vandelli MA; Gómez-Morales MA
    Parasitology; 2011 Sep; 138(11):1384-91. PubMed ID: 21819637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral dosing of neonatal mice with sucrose reduces infection with Cryptosporidium parvum.
    Harp JA
    J Parasitol; 1999 Oct; 85(5):952-5. PubMed ID: 10577733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with agmatine inhibits Cryptosporidium parvum infection in infant mice.
    Moore D; Waters WR; Wannemuehler MJ; Harp JA
    J Parasitol; 2001 Feb; 87(1):211-3. PubMed ID: 11227893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cryptosporidiosis in immunocompromised hosts.
    Zardi EM; Picardi A; Afeltra A
    Chemotherapy; 2005 Jul; 51(4):193-6. PubMed ID: 16006765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection from Cryptosporidium parvum infection by gammadelta T cells in mice that lack alphabeta T cells.
    Eichelberger MC; Suresh P; Rehg JE
    Comp Med; 2000 Jun; 50(3):270-6. PubMed ID: 10894490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory activities of epidermal growth factor receptor tyrosine kinase-targeted dihydroxyisoflavone and trihydroxydeoxybenzoin derivatives on Sarcocystis neurona, Neospora caninum, and Cryptosporidium parvum development.
    Gargala G; Baishanbo A; Favennec L; François A; Ballet JJ; Rossignol JF
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4628-34. PubMed ID: 16251305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility dynamics in neonatal BALB/c mice infected with Cryptosporidium parvum.
    Novak SM; Sterling CR
    J Protozool; 1991; 38(6):103S-104S. PubMed ID: 1818125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feeding activated charcoal from bark containing wood vinegar liquid (nekka-rich) is effective as treatment for cryptosporidiosis in calves.
    Watarai S; Tana ; Koiwa M
    J Dairy Sci; 2008 Apr; 91(4):1458-63. PubMed ID: 18349239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.